Diagnostic value of serum IgG4 for IgG4-related disease

Medicine (United States)

Volumn 95, Issue 21, 2016, Pages

  Hao, Mingju ^a,b,c   Liu, Min ^d   Fan, Gaowei ^a,b   Yang, Xin ^a,b   Li, Jinming ^a,b  

^a BEIJING HOSPITAL   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c SHANDONG UNIVERSITY   (China)

^d Jinan Dermatosis Prevention and Control Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G;

CASE CONTROL STUDY; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMBASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PUBLISHING; REVIEW; SCOPUS; SENSITIVITY ANALYSIS; WEB OF SCIENCE; AUTOIMMUNE DISEASE; BLOOD; META ANALYSIS; ODDS RATIO; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AUTOIMMUNE DISEASES; BIOMARKERS; HUMANS; IMMUNOGLOBULIN G; ODDS RATIO; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 85012840615     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003785     Document Type: Review

References (22)

1. Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease. Annual Rev Pathol Mech Dis. 2014;9:315-347.
2. Culver EL, Vermeulen E, Makuch M, et al. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann Rheum Dis. 2015;74:944-947.
3. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
4. Okazaki K, Umehara H. Are classification criteria for IgG4-RD now possible?. The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol. 2012;2012:357071.
5. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190-195.
6. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
7. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14-18.
8. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22: 419-425.
9. Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-Associated cholangitis from cholangiocarcinoma. Hepatology. 2011;54:940-948.
10. Boonstra K, Culver EL, Wenniger LMD, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-Associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014;59:1954-1963.
11. Ohara H, Nakazawa T, Kawa S, et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol. 2013;28:1247-1251.
12. Li P, Chen H, Deng C, et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related disease in Chinese population. Mod Rheumatol. 2015:1-5.
13. Yu KH, Chan TM, Tsai PH, et al. Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease. Medicine. 2015;94:e1707.
14. Su YY, Sun W, Wang CQ, et al. Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders. Plos One. 2015;10:e0124233.
15. Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4? plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.
16. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-Analysis. J Gastroenterol Hepatol. 2009;24:15-36.
17. Lian MJ, Liu S, Wu GY, et al. Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: a systematic review with meta-Analysis. Clin Res Hepatol Gastroenterol. 2016;40:99-109.
18. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Int Med. 2011;155:529-536.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-Analyses. BMJ. 2003;327:557-560.
20. Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56: 1129-1135.
21. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-358.
22. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1-14.